Article: Chemo Kine Therapeutics Corp. To Appear on MN1.com.

M2 PRESSWIRE-20 September 2006-MN1.com: Chemo Kine Therapeutics Corp. To Appear on MN1.com(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:19092006

VANCOUVER, BC - Hassan Salari, CEO, of Chemo Kine Therapeutics Corp. (OTC BB: CHKT), will be featured live on Market News First (www.mn1.com) for an exclusive interview with the MN1 news team. The interview is scheduled for Sept. 26, 2006, at 2:30PM CDT.

(OTC BB: CHKT) Chemokine Therapeutics Corp. is developing drugs that harness the therapeutic potential of stem cells through chemokine pathways. Chemokines are a class of cytokines, proteins which signal biological responses from stem cells that play a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!